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There is a growing interest in the pharmaceutical industry to design novel tailored drugs 
for RNA targeting. The vertebrate-specific RNase A superfamily is nowadays one of the 
best characterized family of enzymes and comprises proteins involved in host defense 
with specific cytotoxic and immune-modulatory properties. We observe within the family a 
structural variability at the substrate-binding site associated to a diversification of biological 
properties. In this work, we have analyzed the enzyme specificity at the secondary 
base binding site. Towards this end, we have performed a kinetic characterization of 
the canonical RNase types together with a molecular dynamic simulation of selected 
representative family members. The RNases’ catalytic activity and binding interactions 
have been compared using UpA, UpG and UpI dinucleotides. Our results highlight 
an evolutionary trend from lower to higher order vertebrates towards an enhanced 
discrimination power of selectivity for adenine respect to guanine at the secondary base 
binding site (B2). Interestingly, the shift from guanine to adenine preference is achieved in 
all the studied family members by equivalent residues through distinct interaction modes. 
We can identify specific polar and charged side chains that selectively interact with donor 
or acceptor purine groups. Overall, we observe selective bidentate polar and electrostatic 
interactions: Asn to N1/N6 and N6/N7 adenine groups in mammals versus Glu/Asp and 
Arg to N1/N2, N1/O6 and O6/N7 guanine groups in non-mammals. In addition, kinetic 
and molecular dynamics comparative results on UpG versus UpI emphasize the main 
contribution of Glu/Asp interactions to N1/N2 group for guanine selectivity in lower order 
vertebrates. A close inspection at the B2 binding pocket also highlights the principal 
contribution of the protein β6 and L4 loop regions. Significant differences in the orientation 
and extension of the L4 loop could explain how the same residues can participate in 
alternative binding modes. The analysis suggests that within the RNase A superfamily 
an evolution pressure has taken place at the B2 secondary binding site to provide novel 
substrate-recognition patterns. We are confident that a better knowledge of the enzymes’ 
nucleotide recognition pattern would contribute to identify their physiological substrate 
and eventually design applied therapies to modulate their biological functions.
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INTRODUCTION
The interest to solve a biological problem is frequently correlated 
to its inherent difficulty. When entering the RNA world we are 
faced with a wide diversity of secondary and tertiary structures. 
An even higher level of complexity is encountered when 
trying to identify the rules that guide the RNA binding protein 
recognition process. During the last decades, many efforts have 
been applied to unravel the structural determinants for protein 
RNA recognition (Draper, 1999; Allers and Shamoo, 2001; 
Draper, 2015; Terribilini et al., 2007). We are currently witnessing 
significant advances within the RNA field thanks to the novel 
RNA sequencing methodologies that have laid the path to an 
RNA-omics era. Nowadays, we have access to many protein-RNA 
binding predictors (Miao and Westhof, 2016) and the main basic 
rules that drive the protein–nucleotide interaction process have 
been identified (Luscombe, 2001; Denessiouk and Johnson, 2003; 
Morozova et al., 2006; Kondo and Westhof, 2011). The study of 
RNA cleaving enzymes poses additional complexity. Efficient 
RNases should first recognize a specific RNA target, and then 
provide a proper active site configuration to promote catalysis 
and ensure the proper cleavage of the substrate. A particular 
pharmacological interest relies on the design of tailored enzymes 
with specific RNA cleavage targets (Tamkovich et al., 2016). 
Recent work on RNases’ action within a cellular environment is 
helping to unravel their natural in vivo substrates (Honda et al., 
2015; Lyons et al., 2017; Mesitov et al., 2017). A proper knowledge 
of the RNases’ active site architecture should lead to the design of 
specific inhibitors of their biological functions (Chatzileontiadou 
et al., 2015; Chatzileontiadou et al., 2018).
In this work, we have explored the nucleotide base preference 
within the vertebrate-specific RNase A superfamily. The bovine 
pancreatic enzyme RNase A was one of the earliest enzymes to be 
studied in the 20th century and is still one of the best characterized 
(Cuchillo et al., 2011). All the family members share a common 
three-dimensional fold, catalytic triad and mechanism of action 
on single-stranded RNA. During the last decades, the modular 
subsite arrangement of RNase A for the recognition of bases, 
ribose and phosphates has been characterized (Parés et al., 1991; 
Nogués et al., 1998). The enzyme cleaves the 3′5′ phosphodiester 
bonds with specificity for pyrimidines at the main anchoring 
site (B1) and preference for purines at the secondary site (B2) 
(Richards and Wyckoff, 1971; Raines, 1998). In a previous work, 
we analyzed the enzyme residues that were reported to participate 
in the specific binding of adenine (A) and guanine (G) bases at 
the B2 site among the RNase A superfamily members (Boix et al., 
2013). A high evolutionary conservation was observed for B1, 
whereas a significant variability was visualized for the secondary 
base selectivity. Interestingly, the observed structural differences 
at the secondary base site correlate with their substrate specificity 
and catalytic efficiency (Tarragona-Fiol et al., 1993; Sorrentino, 
1998; Boix et al., 2013). Likewise, the analysis of the protein 
conformational changes induced upon nucleotide binding by 
NMR and molecular dynamics highlighted an evolutionary 
trend in base interaction selectivity (Gagné and Doucet, 2013; 
Narayanan et al., 2017; Narayanan et al., 2018a). Conserved 
conformational rearrangements upon ligand binding within 
closely related members suggested a link between shared 
protein networks and their characteristic biological properties 
(Narayanan et al., 2018a). The RNase A superfamily includes a 
series of proteins with antimicrobial and immune-modulatory 
activities and is considered to have emerged with an ancestral 
host-defense role (Boix and Nogués, 2007; Rosenberg, 2008; 
Lu et al., 2018). Family members were classified according to 
their structural, enzymatic and biological properties into eight 
canonical types (Sorrentino and Libonati, 1997; Sorrentino, 
2010). A better understanding of the structural determinants that 
govern the RNases’ substrate specificity can help us to explain the 
divergent functionalities within the family.
Here, we have committed ourselves to undertake a 
comprehensive comparative analysis of representative family 
members and explore the structural drift that has taken place 
through evolution to shape the substrate specificity of the 
secondary base binding site. First, we have performed a kinetic 
characterization of the first seven human canonical RNases using 
dinucleotides. Secondly, we have selected representative RNase A 
superfamily members from lower to higher order vertebrates and 
have performed molecular dynamics simulations of the protein-
dinucleotide complexes.
MATERIALS AND METHODS
Expression and Purification of the 
Recombinant Proteins
RNase A was purchased from Sigma Aldrich. The cDNA for 
RNase 1 was a gift from Prof. Maria Vilanova (University of 
Girona, Spain) and cDNA for RNase 5 was provided by Prof. 
Demetres Leonidas (University of Thessaly, Greece). RNase 4 
synthetic gene was purchased from NZYtech (Lisboa, Portugal) 
and RNase 6 was obtained from DNA 2.0 (Menlo Park, CA, 
USA). RNase 2, RNase 3 and RNase 7 genes were obtained as 
previously described (Torrent et al., 2010). The recombinant 
proteins were expressed and purified as previously described 
(Boix, 2001; Prats-Ejarque et al., 2016). Briefly, the gene was 
cloned into the pET11c expression vector (Novagen), the protein 
was expressed in Escherichia coli BL21(DE3) cells (Novagen) 
and then purified from inclusion bodies. Finally, the protein was 
purified by cationic exchange FPLC on a Resource S column (GE 
Healthcare) and lyophilized. Protein purity was confirmed by 
SDS-PAGE and mass spectrometry.
Spectrophotometric Kinetic Analysis
UpA, UpG and UpI (Biomers, Söflinger, Germany) were used 
as substrates, and the kinetic parameters were determined by a 
spectrophotometric method as described (Boix et al., 1999b). 
Assays were carried out in 50 mM sodium acetate, 1 mM EDTA, 
pH 5.5, at 25°C, using 1 cm path length cuvette. Substrate 
concentration was determined spectrophotometrically using 
the following extinction coefficients: ε260 = 24,600 M−1 cm−1 
for UpA, ε261 = 20,600 M−1 cm−1 for UpG and ε260 = 16,400 
M−1 cm−1 for UpI. The activity was measured by following the 
initial reaction velocities using the difference molar absorbance 
coefficients, in relation to cleaved phosphodiester bonds during 
B2 Specificity in RNaseA SuperfamilyPrats-Ejarque et al.
3 October 2019 | Volume 10 | Article 1170Frontiers in Pharmacology | www.frontiersin.org
the transphosphorylation reaction: Δε286 = 570 M−1 cm−1 for 
UpA, Δε280 = 480 M−1 cm−1 for UpG (Imazawa et al., 1968), Δε280 
= 316 M−1 cm−1 for UpI (experimentally determined). Final 
enzyme concentrations were adjusted depending on the RNase 
activity for each assayed substrate in a range between 0.005 and 
10 μM. The reactions were performed in triplicate with 100 
μM of substrate and the activity was normalized at an enzyme/
substrate ratio of 1:100.
Molecular Dynamics Simulations
All the molecular dynamics (MD) simulations were performed 
using GROMACS 2016.2 (Abraham et al., 2015). The force 
field used was a modification of AMBER99SB (Best and 
Hummer, 2009). Charges of inosine were derived by R.E.D 
server (Vanquelef et al., 2011). The modifications of the force 
field to include inosine parametrization are detailed in the 
Supplemental Materials (Figure S1). All the complexes were 
centred in a dodecahedral cell with a minimum distance box-
solute of 1.0 nm. The unit cell was filled with TIP3P (transferable 
intermolecular potential 3P) water (Jorgensen et al., 1983) in 
neutral pH conditions supplemented with 150 mM of NaCl.
Neighbor search was performed using a Verlet cut-off scheme 
(Páll and Hess, 2013) with a cut-off of 0.9 nm for both Van der 
Waals and coulombic interactions. For long range interactions, 
smooth particle mesh of Ewald (PME) (Darden et al., 1993; 
Essmann et al., 1995) was used with a fourth-order interpolation 
scheme and 0.1125 nm grid spacing for FFT. The bonds were 
constrained with the P-LINCS algorithm (Hess, 2008), with an 
integration time step of 2 fs.
The energy of the systems was minimized using the steepest 
descendant algorithm and equilibrated in two steps. First, an 
initial constant volume equilibration (NVT) of 1 ns was performed 
with a temperature of 300 K using a modified velocity rescaling 
thermostat (Bussi et al., 2007). Then, 1 ns of constant pressure 
equilibration (NPT) was run at 1 bar with a Berendsen barostat 
(Berendsen et al., 1984) at 300 K and the same thermostat. Finally, 
100 ns production runs were performed under an NPT ensemble 
without applying restraints. Three independent simulations in 
periodic boundary conditions were conducted for each complex. 
Dinucleotides were generated by modifying the dCpA ligand of 
an RNase A–d(CpA) complex (Zegers et al., 1994), maintaining 
the same initial coordinates.
RESULTS
Comparison of Canonical RNases’ 
Catalytic Activity on Dinucleotide 
Substrates: A Trend From Guanine to 
Adenine Selectivity At the B2 Secondary 
Base Site
In an effort to deepen into our knowledge of the evolutionary 
pressure that has guided the nucleotide base preference within 
the RNase A superfamily, we have compared the catalytic activity 
of the human canonical members on dinucleotides (Figure 1).
FIGURE 1 | Sequence alignment of the eight canonical human RNases together with the RNase A superfamily members analyzed by molecular dynamics 
(sequences correspond to mature proteins, without the signal peptide). Protein regions identified to participate in B2 site are highlighted in yellow: L4, spanning 
from b2 to b3, end of β6 (residues 109 and 111) and one of the two catalytic histidines together with a close by residue at β7 (residues 119 and 121). TT indicates 
the presence of a β-turn. Dots label every 10 residues of the reference protein used (Bt-RNase 1, known as RNase A). The disulphide bonds are labeled with green 
numbers. Full species names are included in Table S1. Labels are as follows: red box with white character for strict identity; red character for similarity within a 
group; and character with blue frame for similarity across groups. The alignment was performed using Clustal Omega (Sievers and Higgins, 2018), and the picture 
was drawn using ESPript (Robert and Gouet, 2014).
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First, each canonical RNase was expressed using a prokaryote 
recombinant expression system. We successfully expressed 
and purified with high yield the first seven human canonical 
RNases using the T7 promotor and the pET expression system. 
Unfortunately, using the same prokaryote expression system 
we were unable to obtain a properly folded and catalytically 
active human RNase 8. In fact, inspection of the RNase 8 coding 
transcript by Rosenberg and co-workers revealed an unusual 
gene organization and protein disulphide pairing, suggesting a 
significant functional divergence from the canonical characteristic 
structure of the family (Chan et al., 2012). The authors do not 
discard the possibility that RNase 8 is not expressed as a standard 
secretory RNase. Therefore, we decided to perform our kinetic 
study using the first seven human canonical RNases. This is the 
first simultaneous comparison of the catalytic activity of all seven 
proteins within a single laboratory.
The catalytic activity of the RNases was assayed using 
dinucleotide substrates, where the first pyrimidine was kept 
invariable as a uridine and the secondary base was substituted 
by the natural standard purines and the modified base 
inosine. Together with the two natural purines incorporated 
in RNA during transcription, we have also selected inosine, 
a modified base frequently present in cellular RNA, as one of 
the main post-transcriptional modifications. Kinetic activity 
on UpA, UpG and UpI was measured by a spectrophotometric 
assay and the relative preference for the secondary base was 
estimated for each protein. Bovine pancreatic RNase A was 
taken as a reference control.
Interestingly, the respective catalytic activities of the seven 
human canonical RNases indicate a shift of the secondary base 
specificity, from a poor A/G discrimination to a pronounced 
preference for A (Table 1). In particular, the human RNase 
5, which is the canonical member more closely related to 
ancestral RNases (Sorrentino, 2010), shows only a mild 
preference for adenine over guanine. In turn, the pancreatic-
type RNase 1 shows a significant preference for adenine at B2 
position. Last, the more evolved RNase subgroups (types 2/3 
and 6/7) do not have any detectable activity using UpG as a 
substrate (Table 1, Figure 2).
On the other hand, when we analyze the kinetic characterization 
of other family members available in the literature, we can infer 
a shift at the substrate secondary base predilection, from lower 
to higher order vertebrates, from guanine to adenine (Boix et al., 
2013). Basically, the characterized fish, amphibian and reptile 
RNases show a marked preference for G at B2 site (Hsu et al., 2003; 
Ardelt et al., 2008), while mammalian prefer A (Richards and 
Wyckoff, 1971; Zhao et al., 1998; Prats-Ejarque et al., 2016). We 
can group the family members, according to their relative activity 
on dinucleotide substrates, within three main subcategories by 
their base preference at the B2 site: G > A, G ~ A and A > G 
(Figure 2). The results suggest that an evolutionary pressure has 
taken place to promote selectivity for the adenine base within 
the family’s more recently evolved members, coming from an 
ancestral precursor with a marked preference for guanine.
Last, we have studied the RNases’ activity on UpI dinucleotides. 
Inosine (I) was selected as an appropriate model to inspect the 
particular effect of the presence of a C=O group at the purine C6 
atom and the influence of the NH2 group at the C2 position, in 
comparison to the other two purine base structures. Detectable 
activity for the inosine dinucleotide was mainly registered for the 
RNases 1, 2, 4 and 5 (Table 1). Overall, kinetic results indicate 
that no important differences are observed between the proteins’ 
enzymatic activity on UpG and UpI, although a slight preference 
for I over G is shown. Interestingly, the family members that have 
a closer relationship to lower order vertebrates (RNases 1, 4 and 5) 
present a significant activity against dinucleotides with inosine at the 
B2 position, but no detectable activity in the presence of a guanine. 
The results suggest that A/G discrimination within the RNase A 
superfamily relies partly in the recognition of N1/N2 group.
B2 Base Selectivity Within the RNase  
A Superfamily by Molecular Dynamics
Following, to complement the enzymatic characterization of the 
canonical RNases, we performed a comparative analysis within 
the RNase A superfamily by molecular dynamics. To gain insight 
into the structural determinants of the protein recognition 
pattern at the B2 site, we have selected here representative 
members for each vertebrate family subgroup. Ten representative 
RNases were chosen and their binding mode to dinucleotides 
was predicted by MD simulations. Figure 2 illustrates the 
selected proteins and their evolutionary relationships. When no 
TABLE 1 | Kinetic activity of RNase A and the human RNases 1–7. 
V0 (μmol/min) B2 ratio
UpA UpG UpI A/G G/I
Bt-RNase A 0.783 ± 0.033 1.49·10−2 ± 9.99·10−4 3.62·10−2 ± 2.22 ·10−3 52.65 0.411
Hs-RNase 1 0.108 ± 3.93·10−3 1.15·10−3 ± 6.09·10−6 7.87·10−3 ± 5.54 ·10−4 93.63 0.146
Hs-RNase 2 2.57·10−3 ± 1.32·10−4 n.d. 5.53·10−4 ± 1.56 ·10−4 ∞ 0
Hs-RNase 3 2.39·10−3 ± 4.96·10−5 n.d. n.d. ∞ ∞
Hs-RNase 4 5.92·10−2 ± 3.97·10−3 2.38·10−3 ± 2.86·10−4 6.86·10−3 ± 1.7 ·10−4 24.85 0.348
Hs-RNase 5 2.39·10−4 ± 3.74·10−5 1.94·10−5 ± 2.5·10−6 5.33·10−5 ± 8.19 ·10−6 12.29 0.365
Hs-RNase 6 6.74·10−3 ± 1.90·10−4 n.d. n.d. ∞ ∞
Hs-RNase 7 4.25·10−5 ± 6.21·10−6 n.d. n.d. ∞ ∞
The reactions were performed using 100 μM of substrate. Initial velocity (V0) of dinucleotide phosphodiester bond cleavage is indicated. The average of three replicates is shown. 
Standard error of the mean is shown. n.d.: not detected at the assayed conditions. Bt, Bos taurus; Hs, Homo sapiens.
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solved 3D structure was available (RNase 4 of Ornithorhynchus 
anatinus and RNase 1 of Iguana iguana), a prediction model was 
generated using the Modeller software by the ModWeb server 
(Webb and Sali, 2016). From lower to higher order vertebrates, 
the following organisms were analyzed: Danio rerio (Dr), 
Rana pipiens (Rp), Iguana iguana (Ii), Chelonia mydas (Cm), 
Gallus gallus (Gg), Ornithorhynchus anatinus (Oa), Bos taurus 
(Bt) and Homo sapiens (Hs). Representative organisms were 
selected based on the available information on the evolutionary 
relationships and previous structure-functional characterization 
studies (Goo and Cho, 2013). We also indicate, when known, the 
canonical type of each selected RNase (Sorrentino and Libonati, 
1997). Within the placental mammals, we have included two 
representative human members (RNases 2 and 6; UniProtKB 
P10153 and Q93091), which are expressed during infection and 
inflammation and are endowed with a high catalytic activity. 
We have also selected the bovine pancreatic RNase, or RNase 
A (UniProtKB P61823), which is the family reference member 
and one of the best characterized enzymes (Cuchillo et al., 2011). 
Bovine pancreatic RNase belongs to the RNase 1 type. On the 
other hand, for early mammals, we selected the platypus (O. 
anatinus), an egg-laying animal and precursor to higher order 
vertebrates, before divergence of placental RNases. Accordingly, 
the platypus RNase belongs to type 4 (UniProtKB F6ZXU1), 
and was previously identified as the predecessor of higher order 
mammalian RNase types (Goo and Cho, 2013). Following, 
representative members of avian, reptiles, amphibian and fishes 
were chosen, based on the availability of previously solved 3D 
structures. Chicken RNase 1 was taken (UniProtKB P27043) as 
the only member with a known 3D structure (Lomax et al., 2014). 
In turn, reptiles have been represented by turtle (UniProtKB 
P84844) and iguana (UniProtKB P80287) (Nitto et al., 2005). 
Next, we selected the northern leopard frog (R. pipiens) RNase 
(also named Onconase, UniProtKB P22069), which has been 
extensively characterized because of its antitumoral properties 
(Boix et al., 1996; Lee and Raines, 2003; Lee et al., 2008). Lastly, 
for fish representative sequences, we selected D. rerio RNases 
(Dr-RNase 1 and Dr-RNase; UniProtKB A5HAK0 and E7FH77), 
also named as zebrafish RNases 3 and 5 respectively. Both RNases 
were previously reported to display a high catalytic activity in 
comparison to other fish homologues (Cho and Zhang, 2007; 
Pizzo et al., 2011). In particular, the zebrafish 5 (Dr-RNase) was 
classified as one of the most ancestral family members, showing 
a high catalytic activity along with both antimicrobial and 
angiogenic properties (Pizzo et al., 2011). In all cases, previously 
reported 3D structures were taken as a reference, except for the 
platypus RNase, where a prediction model had to be generated.
To compare the RNases’ selectivity at the B2 site, the three 
dinucleotides, UpA, UpG and UpI, were selected (see Figure S3 
for atom nomenclature). Molecular dynamics were performed 
using GROMACS software as detailed in the methodology. 
Triplicates for each protein complex were carried out at 100 
FIGURE 2 | Phylogenetic tree of the RNases studied in the kinetic and molecular dynamics analysis. Right column indicates the UpA/UpG preference ratio 
according to kinetic results (see Table 1). Left column includes the A/G preference at B2 according to the literature. The evolutionary history tree was inferred 
by using the maximum likelihood method and JTT matrix-based model (Jones et al., 1992). The tree with the highest log likelihood (−3745.36) is shown. The 
percentage of trees in which the associated taxa clustered together is shown next to the branches. Initial tree(s) for the heuristic search were obtained automatically 
by applying Neighbour-Join and BioNJ algorithms to a matrix of pairwise distances estimated using a JTT model, and then selecting the topology with superior log 
likelihood value. The tree is scaled, with branch lengths measured as the number of substitutions per site. Evolutionary analyses were conducted in MEGA X (Kumar 
et al., 2018). A more complete phylogenetic tree of RNase A family members is included in Figure S2. Blue star highlights the selected representative RNases to 
perform MD simulation runs.
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ns. The RMSD between the dinucleotide positioning during 
the simulation is shown in Figure S4. The following common 
criteria were established to confirm at the end of each modelling 
run that the nucleotide is positioned in a productive orientation, 
favorable for catalysis: phosphate location at the RNase catalytic 
triad and pyrimidine proximity to B1 site. Equivalent residues to 
RNase A (H12/K41/H119 at the catalytic triad and T45 at B1 site) 
were taken as a reference for each protein.
The dinucleotides’ RMSD fluctuations during each production 
run indicate a reduced substrate mobility, oscillating within a 
value range of 0.1–0.4 nm (Figure S4). The total hydrogen bond 
interactions per residue were calculated for each simulation and 
expressed as a fraction of occurrence. Figure S5 illustrates the 
interacting residues with the purine moieties.
Overall, we observe at the end of each simulation run a similar 
productive positioning of the dinucleotides at the active site cleft 
for most of the studied proteins (Figures 3 and S6). However, 
comparison between all different RNase–nucleotide complexes 
and among triplicates highlights that most variability is located 
at the purine moiety (Figure 4). Likewise, time course analysis 
for each dynamic run shows significantly much higher mobility 
for the purine nucleoside in comparison to the pyrimidine main 
nucleoside and phosphate portions. We can confirm that the 
protein phosphate p1 and base B1 sites are mostly conserved 
among all the family members and provide stronger and more 
specific interactions.
Following, we have analyzed the specific binding interactions at 
the B2 purine portion. Specific binding residues at the B2 site were 
identified. In the majority of complexes, the purine base is fixed 
by the L4 loop and β6 strand structures (Figure 4). Contribution 
of each interacting residue was monitored as a function of time. 
Each run was subdivided into initial, central and late periods. 
Although some mobility of the substrate positioning is observed 
during the 100 ns MD production runs (Figure S4), overall no 
major significant differences are identified as a function of time. 
The most representative interacting residues and atom types 
involved in each modelled complex are summarized in Figure 5.
Figure 5 illustrates the main residues that contribute to B2 
base recognition. The figure indicates the main residues that 
were found involved in interactions with the purine ligand for 
at least one third of the total 100 ns molecular dynamics run. 
We observe the contribution of polar and charged residues that 
act as acceptors/donors to purine representative groups. We 
can identify the protein residues that can provide a bidentate 
anchoring with the purine base and selectively interact with 
unique base groups. In particular, we find specific discriminators 
for adenine (N1/N6 and N6/N7 groups) versus guanine (N1/O6 
and N1/N2 groups). Likewise, discrimination between guanine 
and inosine binding was identified by looking for the residues 
with specific interactions at the base N1/N2 group, unique 
to guanine.
Each studied family member was analyzed taking bovine 
pancreatic RNase A sequence numbering as a reference (see Table 
S2 and Figure 1) (Raines, 1998; Boix et al., 2013). The adenine 
base is fixed in bovine RNase by residues Asn67, Gln69, Asn71, 
Glu111 and His119 (see Figure 5). The reliability of the dynamic 
simulation was first evaluated by comparing the obtained results 
for RNase A using UpA with the previous structural work by 
FIGURE 3 | Schematic illustration of RNase–UpA complexes obtained at the end of the MD 100 ns simulation run. Colors of each vertebrate group are taken 
according to the family phylogenetic tree selection (see Figure S2). Mammal RNases are shown in shades of red, turtle RNase in magenta, chicken RNase in 
orange, frog RNase in green and fish RNase in blue. Some parts of the RNase are colored in gray to allow better visualization of the ligand and the interaction 
regions of the protein. The picture was generated using PyMOL 1.7.2 (Schrödinger, Inc).
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X-ray crystallography on RNase A–dinucleotide complexes 
(Boix et al., 2013). In particular the adenine binding residues 
identified by molecular dynamics were compared with the RNase 
A–d(CpA) complex (Zegers et al., 1994), where the same residues 
for adenine binding had been identified (Asn67, Gln69, Asn71, 
Glu111 and His119). Specific bidentate interactions for adenine 
are provided by Asn71/Gln69 at N1/N6, Asn67 at N6/N7 and 
Glu111 at N6. In particular, our molecular dynamics results 
corroborate the key contribution of all Asn71 counterparts in 
mammalian members for adenine specificity. On the other hand, 
we observe the flexibility of residues such as Glu111, which can 
offer a bidentate anchoring at either the NH2 group at C6 position 
in adenine or at N2/N1 groups in guanine (Figure 5).
In addition, we observe the contribution of the His119 
catalytic residue by π-π interactions with the purine 5-membered 
ring in all the predicted complexes for any of the three assayed 
dinucleotides (Figure 5). Previous structural studies have 
revealed that the catalytic His119 in the free protein can adopt 
two conformations (A and B), where only one rotamer (A) is 
compatible with catalysis and purine interaction (Berisio et al., 
1999; Merlino et al., 2002). Favored stacking interactions of the 
His imidazole with the purine ring are suggested to participate 
in nucleotide discrimination (Gagné and Doucet, 2013). In 
our molecular dynamics study we cannot find any significant 
differences between the complexes obtained with any of the three 
dinucleotide types. On the other hand, significant differences 
are observed for some particular RNases, where the purine ring 
is also establishing cation-π interactions with other residues, 
in particular arginine (such as Arg68 in Hs-RNase 2, Arg66 in 
Gg-RNase, Arg117 in Cm-RNase and Arg8 in Dr-RNase 1 (see 
FIGURE 4 | Overlapping of all RNase-UpA and RNase-UpG complexes 
obtained by molecular dynamics (see Figures 3 and S6). The secondary 
base binding site (B2) is highlighted (loop L4 and strand β6). As shown in 
Figure 3, the molecules are colored according to vertebrate groups as 
indicated in the family phylogenetic tree (see Figure S2). Mammal RNases 
are shown in shades of red, turtle RNase in magenta, chicken RNase in 
orange, frog RNase in green and fish RNase in blue.
FIGURE 5 | Schematic representation of the predominant interactions observed during the 100 ns of each simulation run. Only the interactions present during more 
than 30% of the total dynamic runs were considered. The interactions observed in more than 50% of the total dynamic runs are highlighted in bold. Protein residues 
are listed according to RNase A numbering reference (see Table S2 for structural residues overlapping between the analyzed homologues). Polar and electrostatic 
interactions are detailed for each location. The box labeled with a star includes the shared common van der Waals interactions for the three base types.
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Figure 5). Overall, we observe that most differences among the 
studied family members are located at the L4 Loop. The loop 
mobility is restricted by a disulphide bridge (Cys65–Cys72 pair 
in RNase A), that is conserved in most mammalian RNases 
(except in RNase type5/angiogenin-like), but absent in all the 
non-mammalian vertebrate groups (see Figure 1).
We can conclude from the analysis of predicted protein–
dinucleotide complexes that the main key residues for purine 
interactions (Asn71 and Glu111) are mostly conserved among 
all the studied family members, although distinct binding modes 
are identified depending on the nature of the purine base. Asn71 
in RNase A, and equivalent residues both in human and platypus 
proteins, specifically bind by a bidentate interaction at the N1/
N6 of the adenine ring. Likewise, the Asn side chain can establish 
equivalent interactions for guanine or inosine binding, by shifting 
their NH and C˭O amide groups and thereby interacting with the 
respective N1/O6 groups. However, these interactions are not so 
often observed for guanine/inosine interaction and frequently 
only the Asn binding to the O6 group is identified.
When we inspect the non-mammalian vertebrate members, 
we find a similar scenario: an Asn residue (Asn71 RNase A 
counterpart) can also interact with both N1/N6 groups for A 
and N1/O6 in G/I in turtle, frog and fish proteins. Significant 
differences are found in chicken RNase, where an Arg is located 
at the same position. On its turn, the nearby residue Gln69 
would contribute to provide a specificity for adenine. A Gln 
at this position is only present in the pancreatic RNase 1 type. 
Substitutions of Gln by an Argin Hs-RNases 2 and 6 and platypus 
RNase favor the bidentate interaction with G/I at the N7/O6 
group. The equivalent counterpart in fish is an Asn (), which 
shows a preference for guanine/inosine binding. No equivalent 
residues are found in any other lower order vertebrates, due 
to a deletion in the loop L4 region from residues 65 to 71 (see 
Figures 1 and S7–S11). In addition, we find another Asn residue 
in mammalian RNases that is also favoring the adenine versus 
guanine binding: Asn67 (Figure  5). In this case, the Asn is 
providing a bidentate interaction to N6/N7 adenine groups. The 
presence of an additional Asn is also found in zebrafish RNase 
5 (Dr-RNase) but is missing in all the other studied lower order 
vertebrates. Interestingly, the shorter L4 loop version in the fish 
protein still permits the appropriate Asn positioning.
The molecular dynamics results also highlight two other 
protein regions, which are also participating in the purine 
binding: residues 109–111 (β5) and 119–121 (β6). In particular, 
we observe the main contribution of Glu111 in Bt-RNase A and 
the respective Glu/Asp counterparts in the other studied family 
members (Figure 5 and Table S2). Both the Glu/Asp bidentate 
anionic side chains are observed to bind at both the NH2/N6 
adenine and the N2/N1 guanine specific groups. However, Glu 
substitution by an Asp residue (found in Hs-RNases 2 and 6) 
prevents, or reduces drastically, the base interactions. Similar 
interactions at the adenine N6 NH2 group and the guanine N2/
N1 group are established by Asp121 at Bt-RNase A and their 
counterparts in mammals and chicken RNases. Although a Glu/
Asp is present in all the studied proteins, frog RNases show 
significant differences. Interestingly, the zebrafish 3 counterpart 
(Glu122) interacts with guanine base but is not involved in 
adenine binding. Finally, another substitution that is observed to 
favor guanine binding in non-mammalian RNases is Ala122 to 
Arg. The Arg counterpart residues in fish and turtle RNases can 
interact by bidentate interactions with the O6/N7 group of the 
guanine/inosine bases (Figure 5).
Overall, although key residues for purine binding are mostly 
conserved in all the studied members, such as Asn71, His119 and 
Glu111, our molecular dynamics analysis indicates that distinct 
binding modes could promote a shift from G to A at the B2 site.
An Evolutionary Trend Shaping the B2 
Selectivity Within the RNase A  
Superfamily Lineage
To validate the significance of the residues identified by MD to 
participate in purine recognition, we have supplemented our 
study with the comparative analysis of other family member 
close homologues. Accordingly, each representative member 
analyzed by MD simulations has been compared within its own 
vertebrate subgroup. By close inspection of sequence alignments, 
we have identified the counterpart to the key residues for 
binding of a purine at B2 location. Figures S7–S11 include the 
respective sequence alignments within each vertebrate subgroup. 
The relationships between all the aligned sequences of family 
homologues are illustrated in the phylogenetic tree included in 
Figure S2.
First, we have analyzed the fish RNase sequences, taking as 
a reference D. rerio RNase 1 (Pizzo et al., 2011), also named 
zebrafish RNase 3 (ZF3). Acharya and co-workers solved the 
crystal structure of this RNase together with a polymorphism 
variant (Kazakou et al., 2008). The chosen protein structure 
corresponds to the variant identified as ZF3e. Overall, the 
researchers identified five protein variants, with substitutions 
at six sequence locations. Among them, we observe that one 
of the residues involved in the purine binding (Arg123) is only 
present in the ZF3e polymorphism and is substituted by a Lys 
in the other variant. On the other hand, comparison with the 
other fish RNase sequences (Figure S7) highlights the presence 
of one or two conserved Asn residues at L4 loop region. The loop 
is present in fishes in a short-reduced version in comparison to 
the extended version present in more evolved mammal RNase 
types: 2/3–6/7/8 (Figure 1). However, the Asn residue at position 
72/74 (corresponding to positions 67 and 71 in RNase A) can 
also participate in the adenine interaction but would preferably 
interact with the N1-O6 group of a guanine. Noteworthy, several 
fish RNase sequences display an Asp at 74 position, which 
according to molecular dynamics results is a suitable binder for 
guanine. Two other anionic residues at the protein C-terminus are 
key for the studied RNase complexes; that is Glu114 and Glu122 
(corresponding to Glu111 and Asp121 in RNase A counterparts). 
While most fish RNases show a Glu at 114 position, we also find 
in some cases the presence of an Asp. This is the case of zebrafish 
5 (Pizzo et al., 2011), which was reported to have a relative much 
higher catalytic activity than the other characterized fish RNases 
(Pizzo et al., 2011). Likewise, residue Glu122 is either conserved 
or substituted by an Asp residue. Finally, molecular dynamics 
reveal the presence of an Arg residue at the zebrafish proteins’ 
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N-terminus that shows favored interactions to guanine and 
inosine. The Arg is only present in about 50% of the analyzed 
fish sequences.
Following, we inspected the residues potentially involved in 
purine binding in amphibians. In this vertebrate group we also 
observed a short version of the L4 loop. However, in comparison 
to fish RNases, the analyzed amphibian members show a less 
optimal loop conformation. The loop is orientated to the opposite 
direction respect to RNase A, and lacks one of the key Asn found 
in mammalian RNases. In particular, in northern leopard frog R. 
pipiens RNase (Onconase) we can identify Asn56 (counterpart 
of Asn71 in Bt-RNase A) but no other equivalent residues in 
the region (Figure 1). Comparative structural alignment only 
reveals the presence of a conserved Glu residue at position 91 
(Glu111 counterpart in RNase A). Molecular dynamics results 
on Onconase interaction with dinucleotides have been compared 
with the previous reported solved crystal structure in complex 
with a tetranucleotide (Lee et al., 2008). Raines and co-workers 
studied in detail the enzyme binding to the d(AUGA) substrate 
analogue and observed that while an equivalent binding pocket is 
conserved for the pyrimidine base at B1, significant differences are 
found for the B2 site. In particular, specific bidentate interactions 
of Glu91 with the guanine base were identified at B2 position. 
Moreover, the authors confirmed by site-directed mutagenesis 
that this residue was responsible for the frog RNase preference of 
guanine over adenine. In addition, the authors also highlighted 
the importance of the nature of the nearby residue located at 
position 89 (Onconase counterpart of Ala109 in RNase A). 
Ala109 is conserved in all mammalian and most reptile sequences 
but shows a significant variability in fishes and amphibians. 
Interestingly, ZF3 presents an Ala at this position, as observed 
in mammals, whereas other fish RNases have a polar or cationic 
residue (Thr/Lys or Arg), as observed in frog RNases. Substitution 
of Thr89 in Onconase by an Asn residue reduced the enzyme’s G > 
A preference. The authors suggested that long-range electrostatic 
interactions were key for the enzyme turnover activity on cellular 
RNA substrate in physiological conditions (Lee et al., 2008). The 
hypothesis was further backed up by recent NMR and molecular 
dynamics studies by Doucet and collaborators, that emphasized 
the key role of network interactions connecting distant protein 
residues (Narayanan et  al., 2018a). Interestingly, site-directed 
mutagenesis in Onconase revealed also the contribution of the 
N-terminus in the B2 base discrimination (Lee et al., 2008). 
In particular, insertion of an Arg at position 5 is significantly 
enhancing the frog RNase catalytic activity. Likewise, in our 
molecular dynamics analysis we observe equivalent Arg residues 
at the protein N-terminus of turtle and fish RNases that contribute 
to purine binding (Figure 5 and Table S2).
Molecular dynamics results of Onconase were also compared 
with the structural information reported for bullfrog (R. 
catesbeiana) RNase purified from oocytes (RC-RNase), the most 
catalytically active frog RNase (Chang et al., 1998; Lee and Raines, 
2003). A structural study by NMR of bullfrog oocyte RNase 
analyzed the enzyme interaction with tetranucleotides (Hsu et al., 
2015). The authors reported a much higher catalytic activity for 
oocyte RC-RNase in comparison to RC-RNase 2 and RC-RNase 
4. The contribution of the L4 loop to guanine binding was also 
highlighted, although distinct conformations are observed among 
the bullfrog RNases that could account for the higher catalytic 
activity displayed by the oocyte RC-RNase. When we overlap the 
reported NMR structures with our modelled structures in complex 
with dinucleotides, we also observe that the oocyte RC-RNase is the 
only one that has an Asn residue at an equivalent position to Asn71 
in RNase A, that can establish interactions with the N1-O6 group 
of the guanine. Therefore, the higher catalytic efficiency of bullfrog 
oocyte RNase respect to Onconase could be mostly attributed to 
residue Asn57, which is substituted by a Ser in the latter. When 
we compare the sequence identities of the distinct frog RNases, 
we observe a high variability at the loop L4, where Asn residues 
are mostly substituted by either a Ser or an Asp (Figure  S8). 
Besides, presence of Pro and short amino acid insertions in other 
amphibian RNases might also modify significantly the interaction 
at this site. Interestingly, whereas most R. catesbeiana RNases show 
a particular four amino acid insertion, we found several Xenopus 
species that display an alternative loop version, with a slightly 
extended insert (Figure S8).
In turn, reptiles present a short version of the L4 loop (see 
Figure S9), with a similar length to the one observed in fishes, 
although encompassing a higher sequence divergence at the 
region. In particular, most species include only one Asn within 
the region. In our molecular dynamics study of iguana and turtle 
RNase-dinucleotide complexes we can identify one Asn (Asn68 
in turtle RNase and Asn67 in iguana) equivalent to the Asn71 
counterpart in RNase A (Table S2). Close inspection of sequence 
alignment identifies few reptile species with two Asn residues 
at 67/71 positions (such as the species of the Micrurus or Boiga 
genera), whereas other species show an Asn to Asp substitution 
at position 71. However, we observe an overall higher variability 
at L4 loop, which incorporates non-conserved substitutions 
(Figure  S8). We have also analyzed within reptiles the other 
residues that were identified in turtle or iguana to potentially 
participate in binding at the B2 site (Figure 5). Rosenberg and 
co-workers characterized the RNase from iguana, which is 
mostly expressed in the pancreas and displays a significantly 
high catalytic activity (Nitto et al., 2005). In the present work, 
productive binding conformations obtained by molecular 
dynamics of turtle RNase with dinucleotides highlight the 
contribution at the protein C-terminus of Asp116 and Arg117 
(Asp116, counterpart of Asp121 in RNase A, is only present in 
few reptile sequences). In turn, the presence of an Arg at position 
117, not shared by all the family homologues, is rare.
Avian RNases present the shortest L4 loop version that 
incorporates the most significant deviation from the L4 loop 
consensus sequence (Figure S10). Most L4 sequences do not 
include any Asn residue. In our modelled complex of chicken 
RNase, Asn65 is equivalent to Asn67 in RNase A. However, 
we did not observe any direct participation of Asn65 in purine 
binding. In turn, the neighboring residue Arg66 is significantly 
participating in B2 binding and was observed to bind to any 
of the three purine bases. Arg66 position can be equated to 
Bt-RNase A Asn71 counterpart, although the loop conformation 
is very divergent at this region (Table S2). Arg66 is only found in 
few bird sequences but is located close to Arg66/70 in some other 
mammalian RNases (Hs-RNase 2, Hs-RNase 6 and Oa-RNase 
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in our study; Figure 5 and Table S2). Most strikingly, there is 
no equivalent Glu/Asp counterpart to Bt-RNase A Glu111. On 
the contrary, a Trp is present at that location in the studied 
chicken RNase (Figure  1). Trp is conserved in some chicken 
and snake (Boiga) RNase sequences (Figures S9, S10). In other 
avian sequences we find another bulky hydrophobic residue, 
followed by Asp, which might substitute the Glu111 function. 
Interestingly, in our molecular dynamics study we find the 
contribution of stacking interaction of Trp105 with the purine 
base. On the other hand, the presence of a residue equivalent 
to Asp121 is only observed in some of the sequences, whereas 
others show a substitution by an Ala. In any case, a higher 
proportion of non-productive dinucleotide binding is obtained 
by molecular dynamics (>75% of all run assays) in relation to the 
other studied members (<30% in fish, frog, turtle or platypus), 
which might be attributed to the chicken RNase’s different 
conformations of the L4 loop and the presence of Arg66 and 
Trp105, that tend to establish stacking interactions with the 
purine base. Noteworthy, Rosenberg and co-workers performed 
a comparative study of available sequences for chicken RNases 
and concluded that the evolution within this group of proteins 
might not respond to functional constraints directly related to 
the enzyme catalytic activity (Nitto et al., 2006). Comparison of 
two chicken leukocyte RNases identified key regions for either 
antimicrobial or angiogenic activity. By construction of hybrid 
proteins, they concluded that following a duplication event, a 
selective evolutionary pressure unrelated to the protein enzymatic 
activity had taken place. In our study, we have selected the only 
available 3D structure of a chicken RNase. Unfortunately, this 
RNase corresponds to the angiogenin-type RNase instead of 
the other characterized chicken RNase (leukocyte RNase-A2 or 
RSFR-RNase), which displays a much higher catalytic activity 
(Nitto et al., 2006).
In contrast to lower order vertebrates, we observe that all 
mammalian RNases, except the RNase 5 type, share an extended 
L4 loop fixed by a disulphide bridge (Cys65 and Cys72 in RNase 
A). In contrast, all the non-mammalian vertebrate RNases have 
either a single Cys or none at this location (Figure 1). Mammalian 
RNases’ extended L4 loop includes in all cases the RNase A 
Asn71 counterparts and, in the majority of cases, the RNase A 
Asn67 residue. On the other hand, more variability is observed at 
69 position, where either a Gln, Ser or Arg is found (Figure S11). 
On its side, Glu in position 111 is mostly conserved but can also 
be substituted by an Asp or even a Lys residue. Our MD results 
indicate that the presence of the shorter Asp residue is associated 
in Hs-RNase 2 and Hs-RNase 6 with scarce or null interactions 
with the purine (Figure 5). Structural crystallographic data on 
Hs-RNases 2 and 3 complexes (Mohan et al., 2002) also highlighted 
the different interaction mode of Asp at this position. Hs-RNase 
6 structural studies also indicated that the Glu to Asp substitution 
might significantly modify substrate specificity (Prats-Ejarque 
et al., 2016). On the other hand, it is also interesting to note the 
presence of an Arg at position 122 (Arg132 in RNase 2), which is 
shared with some fish and other lower order vertebrates (Table 
S2) and might provide a significantly differentiated specificity. 
Overall, we can conclude that counterpart residues to Asn71 and 
Glu111 in Bt-RNase A, shared by all the mammalian RNases, 
were already present in most ancestral RNases; but the observed 
purine selective specificity is modulated in each family member 
by complementary interactions of environment residues.
DISCUSSION
The RNase A superfamily is currently a reference model for 
evolutionary and enzymology studies. Although a wealth 
of information is available on ruminant evolution and the 
pancreatic-type RNases (Beintema and Kleineidam, 1998; 
Goo and Cho, 2013; Xu et al., 2013; Lomax et al., 2017), a 
comprehensive full understanding of the whole family is still 
missing. Following a pattern characteristic of host-defense 
proteins, the RNase A family has undergone frequent duplication 
and gene sorting events (Rosenberg et al., 1995; Zhang et al., 
2000; Zhang et al., 2002; Liu et al., 2015). Many studies have 
tried to unveil the structural determinants for the distinct 
RNases’ biological activities (Lu et al., 2018); however, we find 
much less information on the evolutionary trends that shaped 
the family’s enzymatic diversity. Nonetheless, the understanding 
of the evolutionary processes that determined the enzymes’ 
substrate selectivity is key to unravel their physiological roles. 
Distinct nucleotide specificities should respond to an adaptation 
to their respective biological functions (Narayanan et al., 
2018b). Undoubtedly, mastering the structural basis for protein 
nucleotide recognition is essential to assist the design of novel 
anti-infective and immunomodulatory drugs.
Here, we have compared for the first time the catalytic 
activity of the human canonical RNases. The analysis of all the 
recombinant proteins, obtained by the same expression system 
and using the same kinetic characterization methodology, 
ensures a reliable comparative evaluation of their respective 
efficiencies. To unravel the enzyme specificity for the binding of 
the purine secondary base, we have tested the respective catalytic 
activity of the distinct canonical RNases using UpA, UpG and 
UpI dinucleotides as a substrate. Interestingly, when we compare 
the A/G ratio at B2 site for the studied seven canonical RNases 
(Figure 2), we observe a pronounced evolutionary tendency from 
guanine to adenine preference. Previous evolutionary studies 
identified within the RNase A superfamily the phylogenetic 
relationship between the eight canonical subtypes (Cho and 
Zhang, 2007). By comparative analysis of the family coding 
sequences we can order the different RNase types from ancestral 
to modern as follows: 5, 4, 1 and 6/7/8–2/3 group (Zhang, 2007; 
Sorrentino, 2010) (see the family phylogenetic tree in Figure S2). 
Kinetic results of human canonical RNases follow the same 
ordering when considering the UpA/UpG ratio (Table 1). The 
present result is in agreement with previously reported kinetic 
data, where lower order vertebrates, such as amphibians and 
reptiles, show a preference for G (Liao, 1992; Irie et al., 1998), 
while mammalian RNases have a clear preference for A (Boix 
et al., 2013). In addition, the recent kinetic characterization of 
human RNase 6 corroborated the previously reported preference 
for adenine at B2 for human RNases 2 and 3 (Boix et al., 1999a; 
Sikriwal et al., 2007; Prats-Ejarque et al., 2016). On its turn, 
human RNase type 5 shows a much less pronounced preference 
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for adenine over guanine (Acharya et al., 1994; Shapiro, 1998). 
Early kinetic characterization of human RNase 5 (angiogenin) 
already reported its poor discriminating ability on the purine 
located at B2 position (Shapiro et al., 1986; Harper and Vallee, 
1989). Vallee and co-workers engineered an RNase 5 hybrid 
protein by replacing the L4 loop residues 60-70 with the RNase 
A counterparts, successfully enhancing the enzyme catalytic 
activity on UpA dinucleotides (Harper and Vallee, 1989). Further 
work by site-directed mutagenesis in angiogenin suggested that 
an Asn at Gln69 position in RNase A would provide most of 
the purine selective binding. On the contrary, replacement of 
the Glu111 RNase A counterpart (Glu108 in RNase 5) did not 
significantly alter the enzyme B2 selectivity (Curran et al., 1993). 
Indeed, structural and molecular dynamics simulation studies 
indicate that Glu111 in RNase A could contribute to either 
adenine or guanine binding by alternative modes, by direct or 
water-mediated interactions. The nature of the nearby residue 
(109 in RNase A) could determine the potential participation 
of the corresponding Glu residue (Glu111 in RNase A) in the 
purine binding. The hypothesis was elegantly confirmed by site-
directed mutagenesis studies in Onconase (Lee et al., 2008). 
Raines and co-workers demonstrated that the B2 site specificity 
could be shifted from guanine to adenine preference by impeding 
the long distance network interactions that Glu establishes for 
the purine recognition (Lee et al., 2008). Likewise, substitution of 
Glu111 by the shorter Asp side chain in human RNases 2 and 6 
could enhance the adenine versus guanine discriminating power 
in relation to ancestral RNases, such as RNase-type 4 and 5, as 
observed in our kinetic comparison studies (Table 1, Figure 2).
In an effort to unravel the structural determinants underlying 
the observed differentiated kinetic behaviors, we have carried out 
a molecular dynamics analysis of RNase-dinucleotide complexes. 
Representative family members were chosen from lower order 
vertebrates to placental mammals. Overall, molecular dynamics 
corroborate the observed shift from guanine to adenine preference 
by kinetic analysis (Table 1, Figure 2). Notwithstanding, results 
also highlight that conservative sequence identities are frequently 
not accompanied by equivalent substrate binding. A similar 
conclusion was reached by NMR analysis of RNases’ nucleotide 
binding (Narayanan et al., 2018a). Therefore, no straightforward 
conclusions can be directly inferred from the identification 
of individual interactions to nucleotides by mere structural 
overlapping analysis. On the other hand, although molecular 
dynamics considers the protein–ligand complex as an entity in 
motion and provides the equivalent freedom and flexibility that 
could be found in experimental conditions, the methodology 
has also its own limitations when trying to simulate the enzyme 
behavior. Fortunately, Bt-RNase A, the family reference member, 
has been one of the best enzymes ever characterized (Raines, 1998; 
Cuchillo et al., 2011). RNase A was classified by earlier studies 
as an almost “perfect” enzyme, where the transphosphorylation 
state is not limited by the transition state (Albery and Knowles, 
1976). Raines and coworkers analyzed the behaviour of RNase 
A on UpA substrate by experimental kinetics and concluded 
that the cleavage efficiency is mostly limited by the substrate 
desolvation (Thompson et al., 1995). Early crystallographic 
and NMR studies of RNase A in complex with mono-, di- and 
tetranucleotides identified the main residues that conformed 
the RNase A substrate binding subsites (Fontecilla-Camps et al., 
1994; Nogués et al., 1998; Hsu et al., 2015).
Notwithstanding, despite the RNase protein small size and 
structure stability, that facilitated the pioneer biochemistry works 
during the first half of the 20th century, the polymeric nature 
and structural complexity of the substrate is still challenging 
the enzymologists. In this context, it is important to analyze the 
protein family members as a whole dynamic entity. The protein 
has a kidney-shaped structure conformed by two domains that 
delimitate the catalytic active site groove. The open and closed 
conformation of enzymes were compared in the presence of 
nucleotide ligands (Watt et al., 2011; Gagné and Doucet, 2013). 
Key residues involved in the RNase protein motion would have 
co-evolved to shape the enzyme catalytic efficiencies, as described 
for other enzyme families (Maguid et al., 2006; Ramanathan 
and Agarwal, 2011; Narayanan et al., 2018a). Within the RNase 
A superfamily we observed the conservation of key domains 
involved the protein motion (Merlino et al., 2003; Gagné and 
Doucet, 2013). Notwithstanding, comparative studies from lower 
to higher order family members infer an inverse relationship 
between the protein’s structural rigidity and its catalytic efficiency 
(Merlino et al., 2005; Holloway et al., 2011).
Although our molecular dynamics runs using dinucleotides 
are overall in agreement with the reported crystal complex 
structures (Fontecilla-Camps et al., 1994; Zegers et al., 1994; 
Leonidas et al., 2001; Mohan et al., 2002; Lee et al., 2008), we 
do observe some significant differences. This might be due to 
the allowed protein flexibility during the molecular dynamics 
simulations, a fact that could enable a better accommodation 
of the nucleotide substrates. Besides, MD studies permitted 
us to work with the natural enzyme substrates, rather than the 
analogues, commonly used in crystallographic studies. On the 
other hand, NMR titration studies using mononucleotides could 
only mimic the enzyme interactions that were to take place 
with the enzyme reaction product (Narayanan et al., 2018a). 
Interestingly, when we analyze the results of our molecular 
simulation, we can observe significant differences among the 
residues that participate in the distinct periods of the reaction. 
Mostly, interactions with the purine base are frequently lost at 
the end of the production run. Interestingly, in our modelling 
studies we observe how the substitution of Glu111 by an Asp 
residue in human RNases 2 and 6 is only participating in the 
purine binding at the initial step of the reaction. In contrast, the 
positioning of the pyrimidine base, located at the main B1 site, 
and the phosphate are mostly retained during all the simulation 
run, as reported in previous molecular dynamics using RNase A 
or angiogenin (Madhusudhan and Vishveshwara, 2001). Indeed, 
Raines and co-workers’ kinetic studies indicated that the RNase 
A catalytic mechanism relies mostly on the substrate association 
step (delCardayre and Raines, 1994). A high catalytic efficiency 
would mostly be associated to the enzyme facility to throw away 
the product from the catalytic site. In this context, previous 
studies emphasized the importance of the active site flexibility for 
substrate recognition, catalysis and product release (Sanjeev and 
Vishveshwara, 2005; Gagné et al., 2012; Gagné and Doucet, 2013). 
The authors identified two main clusters involved in the protein 
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motion that participate in substrate recognition and product 
release. In particular, L4 loop plays a key role in the protein motion 
(Gagné et al., 2012). In addition, a distant residue, Ala109, was 
identified in RNase A to work as a hinge and promote the active 
cleft opening and product release (Gagné et al., 2015). Ala109 is 
conserved in almost all the studied vertebrate members, except 
in frog and chicken RNases. To note, chicken family members are 
characterized by a much lower catalytic efficiency. On the other 
hand, comparison of zebrafish proteins indicates that presence 
of an Ala or Gly at this position is associated to high catalytic 
efficiency (Kazakou et al., 2008). On the other hand, a network 
of sequential hydrogen bond interactions was found mostly 
dependent on His48 protonation state, where deprotonation is 
associated to product release (Doucet et al., 2009; Watt et al., 
2011). Interestingly, His48 is close to the protein family signature 
CKXXNTF and is conserved in most members, except in fish and 
amphibian sequences (Figures S7–S11).
Early dynamic predictions could also clearly differentiate 
between the main B2 residue (Asn71), which directly interacted 
with the adenine base, and other contributing residues, such as 
residues Gln69 and Glu111, which participated through water-
mediated interactions (Seshadri et al., 1995; Madhusudhan 
and Vishveshwara, 2001). The results helped to interpret 
previous results obtained by site-directed mutagenesis and 
kinetic characterization (Tarragona-Fiol et al., 1993). Likewise, 
the NMR analysis of several frog RNases in complex with a 
deoxytetranucleotide also highlighted the key role of Asn71 
counterparts for guanine binding, even if the respective L4 loops 
are significantly shortened in contrast to the bovine RNase A 
structure (Hsu et al., 2015). Moreover, the studies by Hsu and 
Chen corroborated the importance of Glu111 counterpart in 
specific guanine recognition at the N1/N2 group (Hsu et al., 2015).
On the other hand, significant divergence is evidenced at 
the guanine-binding mode between the present molecular 
dynamics analysis and previous structural characterization by 
X-ray crystallography. Mostly, although our data emphasizes 
the preference for adenine at B2 site in mammal RNases, we 
do not observe any impediment for guanine positioning at the 
enzyme base secondary site, nor any tendency of guanine to bind 
at the main B1 base site. Surprisingly, RNase A crystallographic 
studies using 2′5′-UpG and d(UpG), both in soaking and 
co-crystallization conditions, showed an unusual binding mode 
(Lisgarten et al., 1995). Specifically, the guanine was located at 
B1 instead of B2 site; this peculiar non-productive positioning 
was classified as a “retrobinding” mode (Aguilar et al., 1992). In 
addition, not only was “retrobinding” reported by independent 
researchers for RNase A for both d(CpG) and d(UpG) (Aguilar 
et al., 1992; Lisgarten et al., 1995; Vitagliano et al., 2000), but 
also for bullfrog RNase binding to d(CpA) (Chang et al., 1998). 
Noteworthy, the present kinetic results are also emphasizing a 
much more pronounced substrate selectivity at B2 site than the 
MD data reveal (Table 1, Figure 2).
Overall, our molecular dynamics study using UpA and 
UpG enabled us to outline the main residues involved in the 
RNases’ distinct specificities for B2. Figure 5 illustrates the 
main interactions that participate in the purine recognition. 
First, bidentate interactions can mainly discriminate between 
binding to either adenine or guanine at N1/N6 or N1/O6 groups 
respectively. In addition, we observe specific interactions at N7/
N6 for adenine versus N7/O6 for guanine; and eventually specific 
binding at guanine N1/N2 group. A summary of the most 
representative residues that provide selectivity for each base is 
shown in Figure 6. Although no universal rules can be written 
for protein-nucleotide base binding, the residues identified in 
our study for RNase A superfamily members match most of the 
previously reported in the literature (Luscombe, 2001; Kondo 
and Westhof, 2011). Our previous statistical analysis of protein–
nucleotide complexes available at the Protein Data Bank also 
highlighted the main contribution of Asn/Gln, Arg and Glu/
Asp that provide bidentate interactions at N1/N6 and N1/O6 or 
N1/N2 groups, respectively (Boix et al., 2013). Other polar or 
charged secondary residues, such as Thr, Ser or Lys could also be 
identified (Luscombe, 2001; Boix et al., 2013). Complementarily, 
stacking interactions are also significantly influencing the protein 
binding mode (Luscombe, 2001; Boix et al., 2013). Interestingly, 
another structural feature reported by Westhof and co-workers as 
characteristic for adenine binding is the combined contribution 
of amino acid side chain and the peptide backbone atoms (Kondo 
and Westhof, 2011). Our molecular dynamics analysis highlights 
the conserved binding mode for adenine of Asn71 in RNase A, 
and counterparts, together with L4 loop main chain atoms. This 
emphasizes the importance of Asn and loop L4 conformation 
in RNase A superfamily to favor adenine binding in mammals 
(Figure 4). On their turn, lower order vertebrates tend to present 
an Arg that facilitates the interactions at N7/O6 for guanine 
recognition, as reported for other nucleotide-binding proteins 
(Luscombe, 2001).
Last, together with the two natural purine bases found in RNA 
we decided here to analyse the modified base inosine. Inosine 
molecular structure was used as a purine binding model that 
served to visualize unique interactions at N7/O6 and N1/O6, in 
relation to guanine. Comparison of kinetic and MD results on UpG 
and UpI highlights the importance of specific Glu/Asp residues 
FIGURE 6 | Schematic depiction of the main interactions identified by 
molecular dynamics according to the two main family classes (mammalian 
versus non-mammalian RNases). In dark and light red, the main and 
secondary specific interactions characteristic for either mammalian or non-
mammalian RNases and in grey, the other interactions observed in all the 
RNases analyzed. Representative icon labels for humans and fishes illustrate 
the predominant interaction mode for each RNase class. Asn1 corresponds 
to Asn71 and Asn2 to Asn 67 in RNase A.
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in non-mammalian RNases involved in guanine N1/N2 group 
recognition. Interestingly, we find in the literature an inosine-
specific RNase that can accommodate the base in its active site 
groove and provides specificity by discriminating the modified 
base against the two natural purines (Versées et al., 2002). To 
note, the contribution of Trp side chain in packing the inosine 
base by stacking interactions is observed. Inosine represents 
one of the main posttranscriptional modifications in cellular 
transcripts. RNA modifications not only contribute to regulate 
the translation pathway, they are also involved in the generation 
of regulatory tRNA fragments (Lyons et al., 2018). It is important 
to highlight that specific tRNA cleavage participates in the host 
response in stress conditions (Thompson et al., 2008) and RNA 
posttranscriptional modification can alter the target specificity for 
cellular endonucleases. For example, base methylation can protect 
tRNA from cleavage by human RNase 5 (angiogenin) (Lyons 
et al., 2017). Overall, RNA modifications not only alter their own 
processing rate but also influence their association to selective 
binding proteins, participating in the cellular metabolism and 
physiology (Boccaletto et al., 2017). Besides, the complexity of 
cellular RNA structure and its organization into supramolecular 
complexes within the cell further difficult our understanding of 
the cellular RNA metabolism (Van Treeck et al., 2018). Definitely, 
we are still facing important methodological limitations to 
interpret the RNases’ behavior in physiological conditions.
On the other hand, a comprehensive analysis of the protein 
nucleotide recognition pattern cannot disregard the existence of 
an extended substrate binding site architecture as demonstrated 
by many structural and kinetic studies (Boix et al., 1994; 
Fontecilla-Camps et al., 1994; Irie et al., 1998; Nogués et al., 
1998; Raines, 1998; Hsu et al., 2015; Prats-Ejarque et al., 2019). 
Interestingly, recent work on the protein motion and ligand 
binding energies using a pentanucleotide suggests that induced 
conformational changes take place upon RNA interaction with 
secondary binding sites and can eventually provide a synergistic 
addition effect (Narayanan et al., 2017). The cooperative 
participation of secondary substrate binding sites could explain 
the enzyme low binding affinity for mono- and dinucleotides and 
is also significantly limiting the potency of molecular dynamics 
predictions, when working with such probes. However, our 
present results, together with previously reported data, are 
definitely indicating an evolutionary trend in B2 base selectivity 
within the vertebrate-specific RNase A superfamily that should 
respond to changing environmental conditions and adaptation 
to novel physiological needs. There is still a long path to walk to 
unveil the RNases’ substrate selectivity in vivo. We are confident 
that the identification of the structural patterns for nucleotide 
recognition in host defense RNases would provide valuable tools 
for structure-based drug design.
CONCLUSIONS
In this work, we have analysed the base selectivity at B2 site 
within the RNase A superfamily by kinetic assays and molecular 
dynamics simulations using dinucleotide substrates. Our 
results indicate an evolutionary drift tendency from guanine 
to adenine preference. Interestingly, a close inspection of the 
residues potentially involved in the enzyme B2 site reveals that 
the main contributors (Asn71 and Glu111 in RNase A and 
equivalent counterparts) are present in all the family members. 
Notwithstanding, significant differences in L4 loop extension 
and contribution of complementary residues can facilitate a 
distinct binding mode that confers discrimination between 
both purine bases. Overall, Asn, Glu/Asp and Arg bidentate side 
chains provide selective binding to adenine N1/N6 and N6/N7 
versus guanine N1/O6, O6/N7 and N1/N2 groups.
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SUPPLEMENTARY FIGURE 1 | Modifications of the force field to include 
inosine parametrization.
SUPPLEMENTARY FIGURE 2 | Phylogenetic tree of representative sequences 
of pancreatic ribonucleases. The evolutionary history was inferred by using the 
Maximum Likelihood method and JTT matrix-based model (Jones et al., 1992). 
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The tree with the highest log likelihood (−27534.43) is shown. The percentage 
of trees in which the associated taxa clustered together is shown next to the 
branches. Initial tree(s) for the heuristic search were obtained automatically by 
applying Neighbour-Join and BioNJ algorithms to a matrix of pairwise distances 
estimated using a JTT model, and then selecting the topology with superior 
log likelihood value. The tree is drawn to scale, with branch lengths measured 
in the number of substitutions per site. This analysis involved 160 amino acid 
sequences. There were a total of 212 positions in the final dataset. Evolutionary 
analyses were conducted in MEGA X (Kumar et al., 2018). RNases are labeled 
with the species abbreviation (see Table S1) and its UNIPROT code, or, in its 
absence, with its NCBI code.
SUPPLEMENTARY FIGURE 3 | Atom nomenclature of the three dinucleotides 
used in the molecular dynamics simulations.
SUPPLEMENTARY FIGURE 4 | Mobility of the dinucleotides, calculated 
in RMSD (nm), during each 100 ns simulation run. Each color represents a 
different replicate.
SUPPLEMENTARY FIGURE 5 | Fraction of hydrogen bond interaction 
occurrence of the key protein residues involved in the binding to the purine base 
during each MD simulation run.
SUPPLEMENTARY FIGURE 6 | Schematic illustration of RNase-UpG 
complexes obtained by molecular dynamics simulations using GROMACS. The 
picture was generated using PyMOL 1.7.2 (Schrödinger, Inc).
SUPPLEMENTARY FIGURE 7 |Sequence alignment of representative 
sequences of fish RNases. Protein regions identified to participate in B2 site 
are highlighted in yellow (L4, spanning from b2 to b3, end of β6 and one of the 
two catalytic histidines together with a close by residue at β7). Main conserved 
key residues are: Asn 72/74, Glu 114 and Glu 122/Arg123. TT indicates the 
presence of a β-turn. Dots label every 10 residues of the reference protein 
used (Dr-RNase 1). The disulphide bonds are labeled with green numbers. The 
alignment was performed using Clustal Omega (Sievers and Higgins, 2018), 
and the picture was drawn using ESPript (Robert and Gouet, 2014). Labels are 
as follows: red box, white character for strict identity; red character for similarity 
within a group; and character with blue frame for similarity across groups.
SUPPLEMENTARY FIGURE 8 | Sequence alignment of representative 
sequences of amphibian RNases. Protein regions identified to participate in 
B2 site are highlighted in yellow (L4, spanning from b2 to b3, end of β6 and 
one of the two catalytic histidines together with a close by residue at β7). Main 
conserved key residues are: Arg5, Asn56 and Thr89/Glu91. TT indicates the 
presence of a β-turn. Dots label every 10 residues of the reference protein 
used (Rp-RNase). The disulphide bonds are labelled with green numbers. The 
alignment was performed using Clustal Omega (Sievers and Higgins, 2018), 
and the picture was drawn using ESPript (Robert and Gouet, 2014). Labels are 
as follows: red box, white character for strict identity; red character for similarity 
within a group; and character with blue frame for similarity across groups.
SUPPLEMENTARY FIGURE 9 | Sequence alignment of representative 
sequences of reptilian RNases. Protein regions identified to participate in B2 site 
are highlighted in yellow (L4, spanning from b2 to b3, end of β6 and one of the 
two catalytic histidines together with a close by residue at β7). Main conserved 
key residues are: Asn68 and Asp116/Arg117. TT indicates the presence of a 
β-turn. Dots label every 10 residues of the reference protein used (Cm-RNase 
1). The disulphide bonds are labelled with green numbers. The alignment was 
performed using Clustal Omega (Sievers and Higgins, 2018), and the picture was 
drawn using ESPript (Robert and Gouet, 2014). Labels are as follows: red box, 
white character for strict identity; red character for similarity within a group; and 
character with blue frame for similarity across groups.
SUPPLEMENTARY FIGURE 10 | Sequence alignment of representative 
sequences of bird RNases. Protein regions identified to participate in B2 site 
are highlighted in yellow (L4, spanning from b2 to b3, end of β6 and one of the 
two catalytic histidines together with a close by residue at β7). Main conserved 
key residues are: Asn65, Arg66 and Trp105. TT indicates the presence of a 
β-turn. Dots label every 10 residues of the reference protein used (Gg-RNase 
1). The disulphide bonds are labelled with green numbers. The alignment was 
performed using Clustal Omega (Sievers and Higgins, 2018), and the picture was 
drawn using ESPript (Robert and Gouet, 2014). Labels are as follows: red box, 
white character for strict identity; red character for similarity within a group; and 
character with blue frame for similarity across groups.
SUPPLEMENTARY FIGURE 11 | Sequence alignment of representative 
sequences of mammalian RNases. Protein regions identified to participate in B2 
site are highlighted in yellow (L4, spanning from b2 to b3, end of β6 and one of the 
two catalytic histidines together with a close by residue at β7). Main conserved 
key residues are: Asn67/Gln69/Asn71, Ala109, Glu111 and Arg122. TT indicates 
the presence of a β-turn. Dots label every 10 residues of the reference protein 
used (Bt-RNase 1). The disulphide bonds are labelled with green numbers. The 
alignment was performed using Clustal Omega (Sievers and Higgins, 2018), 
and the picture was drawn using ESPript (Robert and Gouet, 2014). Labels are 
as follows: red box, white character for strict identity; red character for similarity 
within a group; and character with blue frame for similarity across groups.
SUPPLEMENTARY TABLE 1 | Phylogenetic classification and abbreviations 
used for the analysed species.
SUPPLEMENTARY TABLE 2 | Main key residues identified by molecular 
dynamic simulations of the studied RNase complexes with UpA, UpG and UpI. 
Equivalent residues by structural superposition are indicated. Cationic residues 
are indicated in blue, anionic residues in red and polar residues in black. Histidine 
residues involved in stacking interactions with the purine base are coloured 
in orange. Only specific interactions with purine atoms are included. Specific 
interaction to purine atoms are illustrated in Figure 5.
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